These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12454742)

  • 21. Human K562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activity.
    Wong SC; McQuade R; Proefke SA; Bhushan A; Matherly LH
    Biochem Pharmacol; 1997 Jan; 53(2):199-206. PubMed ID: 9037252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
    Zhao R; Gao F; Babani S; Goldman ID
    Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
    Matherly LH; Angeles SM; McGuire JJ
    Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.
    Jansen G; Westerhof GR; Jarmuszewski MJ; Kathmann I; Rijksen G; Schornagel JH
    J Biol Chem; 1990 Oct; 265(30):18272-7. PubMed ID: 2211701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variable expression of RFC1 in human leukemia cell lines resistant to antifolates.
    Kobayashi H; Takemura Y; Ohnuma T
    Cancer Lett; 1998 Feb; 124(2):135-42. PubMed ID: 9500202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5,10-Dideazatetrahydrofolic acid (DDATHF) transport in CCRF-CEM and MA104 cell lines.
    Pizzorno G; Cashmore AR; Moroson BA; Cross AD; Smith AK; Marling-Cason M; Kamen BA; Beardsley GP
    J Biol Chem; 1993 Jan; 268(2):1017-23. PubMed ID: 8419310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.
    Moscow JA; Connolly T; Myers TG; Cheng CC; Paull K; Cowan KH
    Int J Cancer; 1997 Jul; 72(1):184-90. PubMed ID: 9212241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
    Spinella MJ; Brigle KE; Sierra EE; Goldman ID
    J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
    Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
    Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concentrating capacity of the human reduced folate carrier (hRFC1) in human ZR-75 breast cancer cell lines.
    Sharif KA; Moscow JA; Goldman ID
    Biochem Pharmacol; 1998 May; 55(10):1683-9. PubMed ID: 9634005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers.
    Whetstine JR; Gifford AJ; Witt T; Liu XY; Flatley RM; Norris M; Haber M; Taub JW; Ravindranath Y; Matherly LH
    Clin Cancer Res; 2001 Nov; 7(11):3416-22. PubMed ID: 11705857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells.
    Roy K; Tolner B; Chiao JH; Sirotnak FM
    J Biol Chem; 1998 Jan; 273(5):2526-31. PubMed ID: 9446553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxicity of methotrexate and trimetrexate and its reversal by folinic acid in human leukemic CCRF-CEM cells with carrier-mediated and receptor-mediated folate uptake.
    van der Veer LJ; Westerhof GR; Rijksen G; Schornagel JH; Jansen G
    Leuk Res; 1989; 13(11):981-7. PubMed ID: 2532692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular events in the membrane transport of methotrexate in human CCRF-CEM leukemia cell lines.
    Freisheim JH; Ratnam M; McAlinden TP; Prasad KM; Williams FE; Westerhof GR; Schornagel JH; Jansen G
    Adv Enzyme Regul; 1992; 32():17-31. PubMed ID: 1323203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate transport and resistance.
    Moscow JA
    Leuk Lymphoma; 1998 Jul; 30(3-4):215-24. PubMed ID: 9713954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
    Sierra EE; Goldman ID
    Biochem Pharmacol; 1998 May; 55(9):1505-12. PubMed ID: 10076544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells.
    Drori S; Sprecher H; Shemer G; Jansen G; Goldman ID; Assaraf YG
    Eur J Biochem; 2000 Feb; 267(3):690-702. PubMed ID: 10651805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereoselective transport of human His27- and Arg27-reduced folate carrier.
    Narawa T; Yanagisawa H; Itoh T
    Biol Pharm Bull; 2014; 37(3):439-46. PubMed ID: 24583862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
    McGuire JJ; Haile WH; Yeh CC
    Cancer Res; 2006 Apr; 66(7):3836-44. PubMed ID: 16585211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.